How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

995 results for

Spondyloarthropathy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

281. Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot Study

spondyloarthropathy, fibromyalgia, radiculopathy, symptomatic spinal stenosis, facetogenic or discogenic low back pain, generalized infection, localized infection in the area of the low back/SIJs, coagulopathy or anticoagulation, allergy to local anesthetic Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its

2015 Clinical Trials

282. Ocular Involvement in Systemic Autoimmune Diseases. (Abstract)

Ocular Involvement in Systemic Autoimmune Diseases. Eye involvement represents a common finding in patients with systemic autoimmune diseases, particularly rheumatoid arthritis, Sjogren syndrome, seronegative spondyloarthropathy, and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. The eye is a privileged immune site but commensal bacteria are found on the ocular surface. The eye injury may be inflammatory, vascular or infectious, as well as iatrogenic, as in the case

2015 Clinical Reviews in Allergy & Immunology

283. Patient-physician discordance in global assessment in early spondyloarthritis and its change over time: the DESIR cohort. Full Text available with Trip Pro

Patient-physician discordance in global assessment in early spondyloarthritis and its change over time: the DESIR cohort. To assess patient-physician discordance in global assessment of disease activity in early axial spondyloarthritis (axSpA) over time and determinants of discordance.DESIR (Devenir des Spondyloarthropathies Indifférenciées Récentes) is a French, multicentre, longitudinal cohort of patients with early inflammatory back pain suggestive of axSpA. Patient global assessment (PGA

2015 Annals of the Rheumatic Diseases

284. Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis

of, or current inflammatory joint disease other than RA (e.g., gout, Lyme disease, seronegative spondyloarthropathy including reactive arthritis, psoriatic arthritis, arthropathy of inflammatory bowel disease). Relatively significant radiation exposure over the course of the year prior to randomization. Significant exposure is defined as: i) More than 2 PCI within 12 months of randomization ii) More than 2 myocardial perfusion studies within the past 12 months iii) More than 2 CT angiograms within the past

2015 Clinical Trials

285. Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants

the discretion of the investigator Diagnosed with juvenile idiopathic arthritis or juvenile RA and/or RA before the age of 16 years Prior or current inflammatory joint disease other than RA (for example, gout, Lyme disease, sero-negative spondyloarthropathy, including reactive arthritis, psoriatic arthritis, arthropathy of inflammatory bowel disease), or prior or current joint infections Previous history of primary or secondary adrenal insufficiency Previous or Concomitant Prohibited Therapy Treatment

2015 Clinical Trials

286. Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis

; A medical history of inflammatory arthritis (IA) of any type and/or rheumatic disease and immunologic disease(s) that may be associated with IA . These diseases include but are not limited to: rheumatoid arthritis (RA); systemic lupus erythematosus (SLE); seronegative spondyloarthropathies; inflammatory bowel disease; Sjögren's syndrome; polymyalgia rheumatic; or vasculitis. Note: Crystalline arthropathies are not exclusionary. A medical history of: congestive heart failure or functional status of New

2015 Clinical Trials

287. Kinesio Taping Efficacy in Chronic Low Back Pain Treatment (KITALO)

structures, spondyloarthropathy, spondylodiscitis). Prior spine surgery. Mental retardation, severe mental illness, substance abuse or dependency, illiteracy. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02604290 Locations Layout table for location

2015 Clinical Trials

288. Fibrocytes in Early and Longstanding Rheumatoid Arthritis

disease (MCTD), scleroderma, polymyositis or primary vasculitis. History of or current inflammatory joint disease other than RA (e.g. gout, reactive arthritis, psoriatic arthritis, spondyloarthropathy, Lyme disease). Allergy to local aesthetics. Hereditary or acquired (e.g. Anticoagulant Treatment, apart from low dose aspirin) coagulation abnormality. Prednisolone above 7.5 mg/day Skin pathology at site of joint biopsy. Obesity, BMI > 30. Functional class IV as defined by the criteria

2015 Clinical Trials

289. Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA.

of more than 6 months. Subject must have a diagnosis of active PsA by Classification Criteria for Psoriatic Arthritis (CASPAR) and has disease duration of more than 6 months. The subject must be able to provide written informed consent and to complete the study questionnaires. Exclusion Criteria: Subject with DIP involvement in PsA Subject with predominant axial symptoms (spondyloarthropathy) Subject with fibromyalgia Subject involved in a concomitant study Subject currently takes ≥10 mg cortisone

2015 Clinical Trials

290. A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

after stopping treatment Have been treated with 1 or more conventional disease-modifying antirheumatic drugs (cDMARDs) Exclusion Criteria: Current or prior use of biologic agents for treatment of Ps or PsA Inadequate response to greater than or equal to 4 conventional disease-modifying antirheumatic drugs (DMARDS) Current use of more than one cDMARDs Diagnosis of active inflammatory arthritic syndromes or spondyloarthropathies other than PsA Have received treatment with interleukin (IL) -17 or IL12

2015 Clinical Trials

291. Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study

such as systemic lupus erythematosus, mixed connective tissue disease, scleroderma, polymyositis, or significant systemic involvement secondary to rheumatoid arthritis. Con-current immunosuppression/immunomodulatory treatment (Calcineurin inhibitor, anti-proliferative or biologic) therapy for other reason i.e. organ transplant. Prior history or current inflammatory joint disease other than gout (e.g. rheumatoid arthritis (RA), reactive arthritis, psoriatic arthritis, seronegative spondyloarthropathy, Lyme

2015 Clinical Trials

292. Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate

antirheumatic drugs for the treatment of RA. Have a history of or currently inflammatory joint disease other than RA (e.g., gout, reactive arthritis, psoriatic arthritis, seronegative spondyloarthropathy, or Lyme disease) or other systemic autoimmune disorder (eg, systemic lupus erythematosus, inflammatory bowel disease, scleroderma, inflammatory myopathy, mixed connective tissue disease, or other overlap syndrome). Has any major systemic features of RA, for example, Felty's syndrome, vasculitis

2015 Clinical Trials

293. Lower PHQ-9 cutpoint accurately diagnosed depression in people with long-term conditions attending the Accident and Emergency Department. (Abstract)

and chronic inflammatory rheumatic diseases, mainly rheumatoid arthritis and spondyloarthropathies, visiting an AED. The MINI interview was used as the criterion standard for MDD. Receiver operator characteristic (ROC) curve analysis was performed to determine the optimal PHQ-9 cutpoint for MDD. Construct validators included psychological distress (SCL-90-R), illness perceptions (B-IPQ) and Health-Related Quality of Life (WHOQOL-BREF).The prevalence of MDD was 27.2%. At an optimal cutpoint of 8, PHQ-9 had

2015 Journal of Affective Disorders

294. Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis Full Text available with Trip Pro

patients (SAP, n = 31), spondyloarthropathy patients (SpA, n = 26) and healthy controls (HC, n = 31) were assayed.In RA SF, LLT1 was expressed by a small proportion of monocytes. In RA ST, LLT1-expressing cells were detected in the lining, sublining layer and in areas with infiltrates. The LLT1 staining pattern overlapped with the CD68 staining pattern. FACS analysis of digested ST confirmed LLT1 expression by CD68+ cells. Elevated systemic sLLT1 was found in all patient groups.In RA joints, LLT1 (...) is expressed by cells of the monocyte/macrophage lineage. Serum levels of sLLT1 were increased in all patient groups (patients with early- and late-stage RA, seropositive arthralgia and spondyloarthropathy) when compared to healthy subjects.

2015 PloS one

295. Reactive arthritis. Full Text available with Trip Pro

Reactive arthritis. Reactive arthritis (ReA) is an immune-mediated seronegative arthritis that belongs to the group of spondyloarthropathies and develops after a gastrointestinal or genitourinary system infection. The condition is considered to be characterized by a triad of symptoms (conjunctivitis, arthritis and urethritis) although a constellation of other manifestations may also be present. ReA is characterized by psoriasiform dermatological manifestations that may resemble those

2015 Journal of the European Academy of Dermatology and Venereology

296. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. Full Text available with Trip Pro

reported in Europe. HS has the highest impact on patients' quality of life among all assessed dermatological diseases. HS is associated with a variety of concomitant and secondary diseases, such as obesity, metabolic syndrome, inflammatory bowel disease, e.g. Crohn's disease, spondyloarthropathy, follicular occlusion syndrome and other hyperergic diseases. The central pathogenic event in HS is believed to be the occlusion of the upper part of the hair follicle leading to a perifollicular lympho

2015 Journal of the European Academy of Dermatology and Venereology

297. The Rate of Helicobacter pylori Seropositivity in a Group of Korean Patients with HLA-B27-Associated Acute Anterior Uveitis Full Text available with Trip Pro

The Rate of Helicobacter pylori Seropositivity in a Group of Korean Patients with HLA-B27-Associated Acute Anterior Uveitis To investigate an association between Helicobacter pylori seropositivity and HLA-B27-positive acute anterior uveitis (AAU) in Korean patients.Retrospective analysis was performed with data from 106 patients previously diagnosed with AAU without clinical evidence of spondyloarthropathy. Serum immunoglobulin G antibodies to H. pylori were measured by enzyme-linked

2015 PloS one

298. Spontaneous Ankylosis of Occiput to C2 following Closed Traction and Halo Treatment of Atlantoaxial Rotary Fixation Full Text available with Trip Pro

and the halo vest was removed after 3 months. At late follow-up, computed tomography demonstrated complete bony ankylosis of the occiput to C2. The patient was found to be HLA B27-positive, but he had no family history of ankylosing spondyloarthropathy or other joint symptoms. The underlying reasons for spontaneous fusion of the occiput to C2 could include the traction, HLA-B27-related spondyloarthropathy, or arthropathic changes caused by traction, reduction, the inciting insult, or immobilization

2015 Global spine journal

299. Heterogeneity of Synovial Molecular Patterns in Patients with Arthritis Full Text available with Trip Pro

biopsies of patients with arthritis, using low-density platforms.Low-density assays (cDNA microarray and microfluidics qPCR) were designed, based on the results of the high-density microarray data. Knee synovial biopsies were obtained from patients with RA, spondyloarthropathies (SA) or osteoarthritis (OA) (n = 39), and also from patients with initial undifferentiated arthritis (UA) (n = 49).According to high-density microarray data, several molecular pathways are differentially expressed in patients

2015 PloS one

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>